National Research Corp Stock Performance
| NRC Stock | USD 19.66 0.18 0.92% |
The company secures a Beta (Market Risk) of 1.77, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, National Research will likely underperform. At this point, National Research Corp has a negative expected return of -0.15%. Please make sure to verify National Research's kurtosis, as well as the relationship between the day median price and relative strength index , to decide if National Research Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days National Research Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return 0.92 | Five Day Return 1.34 | Year To Date Return (52.28) | Ten Year Return 42.26 | All Time Return (21.39) |
Forward Dividend Yield 0.0246 | Payout Ratio 0.4274 | Forward Dividend Rate 0.48 | Dividend Date 2025-01-10 | Ex Dividend Date 2024-12-27 |
1 | Acquisition by Karas Kevin R of 10981 shares of National Research subject to Rule 16b-3 | 09/11/2024 |
2 | NRC exemption for Hermes 2 test reactor shows nuclear licensing progress NIA | 09/17/2024 |
3 | Palisades steam generators require repair before restart, nuclear authority says | 10/03/2024 |
| National Research dividend paid on 11th of October 2024 | 10/11/2024 |
4 | Google to buy power for AI needs from small modular nuclear reactor company Kairos | 10/14/2024 |
5 | Conestoga Capital Advisors Sold National Research Corp. , as it Fell Short of Expectations | 10/22/2024 |
6 | National Research Q3 Earnings Snapshot | 10/25/2024 |
7 | Cooper University Health Care Selects NRC Health as New Patient Experience Partner | 11/12/2024 |
8 | National Research Corp announces CFO retirement | 11/14/2024 |
9 | Amgen Inc. Shares Sold by AMG National Trust Bank - MarketBeat | 11/19/2024 |
10 | National Research Will Want To Turn Around Its Return Trends | 11/27/2024 |
| Begin Period Cash Flow | 25 M |
National |
National Research Relative Risk vs. Return Landscape
If you would invest 2,205 in National Research Corp on September 1, 2024 and sell it today you would lose (239.00) from holding National Research Corp or give up 10.84% of portfolio value over 90 days. National Research Corp is generating negative expected returns assuming volatility of 2.5932% on return distribution over 90 days investment horizon. In other words, 23% of stocks are less volatile than National, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
National Research Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for National Research's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as National Research Corp, and traders can use it to determine the average amount a National Research's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0574
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NRC |
Estimated Market Risk
| 2.59 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average National Research is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of National Research by adding National Research to a well-diversified portfolio.
National Research Fundamentals Growth
National Stock prices reflect investors' perceptions of the future prospects and financial health of National Research, and National Research fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on National Stock performance.
| Return On Equity | 0.59 | ||||
| Return On Asset | 0.19 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 507.48 M | ||||
| Shares Outstanding | 23.48 M | ||||
| Price To Earning | 26.72 X | ||||
| Price To Book | 13.21 X | ||||
| Price To Sales | 3.20 X | ||||
| Revenue | 148.58 M | ||||
| Gross Profit | 94.52 M | ||||
| EBITDA | 45.98 M | ||||
| Net Income | 30.97 M | ||||
| Cash And Equivalents | 32.97 M | ||||
| Cash Per Share | 1.33 X | ||||
| Total Debt | 38.96 M | ||||
| Debt To Equity | 0.37 % | ||||
| Current Ratio | 1.31 X | ||||
| Book Value Per Share | 1.48 X | ||||
| Cash Flow From Operations | 38.11 M | ||||
| Earnings Per Share | 1.12 X | ||||
| Market Capitalization | 461.54 M | ||||
| Total Asset | 122.44 M | ||||
| Retained Earnings | (30.53 M) | ||||
| Working Capital | (11.84 M) | ||||
| Current Asset | 27.6 M | ||||
| Current Liabilities | 12.83 M | ||||
About National Research Performance
By analyzing National Research's fundamental ratios, stakeholders can gain valuable insights into National Research's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if National Research has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if National Research has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.52 | 0.55 | |
| Return On Capital Employed | 0.46 | 0.28 | |
| Return On Assets | 0.25 | 0.20 | |
| Return On Equity | 0.63 | 0.48 |
Things to note about National Research Corp performance evaluation
Checking the ongoing alerts about National Research for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for National Research Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| National Research generated a negative expected return over the last 90 days | |
| National Research has a frail financial position based on the latest SEC disclosures | |
| About 37.0% of the company outstanding shares are owned by corporate insiders | |
| On 11th of October 2024 National Research paid $ 0.12 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: National Research Will Want To Turn Around Its Return Trends |
- Analyzing National Research's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether National Research's stock is overvalued or undervalued compared to its peers.
- Examining National Research's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating National Research's management team can have a significant impact on its success or failure. Reviewing the track record and experience of National Research's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of National Research's stock. These opinions can provide insight into National Research's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for National Stock analysis
When running National Research's price analysis, check to measure National Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Research is operating at the current time. Most of National Research's value examination focuses on studying past and present price action to predict the probability of National Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Research's price. Additionally, you may evaluate how the addition of National Research to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |